Back to search
FDAFDA · Food and drugs·Recall number D-1319-2022

Miralax (Polyethylene Glycol 3350), Powder for Solution, Osmotic Laxative, 30 Once-Daily Doses, Net WT 17.9 OZ (510 g) bottle, Bayer Healthcare Pharmaceuticals, NDC 11523-7234-4.

Published August 17, 2022 · Recall initiated: June 29, 2022

Summary

FDA records drug Class II recall D-1319-2022, published August 17, 2022 and initiated June 29, 2022. Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office; Status: Terminated; Reported quantity: 67 bottles; Lot: Part# 11523723404. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: products were stored outside the drug label specifications.

What to do

Voluntary: Firm initiated · Letter

Get an email if MIRALAX has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MIRALAX
Manufacturer
Mckesson Medical-Surgical Inc. Corporate Office
Distributor
Nationwide in the USA.
UPC
0041100820716
Lot
Part# 11523723404
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Miralax (Polyethylene Glycol 3350), Powder for Solution, Osmotic Laxative, 30 Once-Daily Doses, Net WT 17.9 OZ (510 g) bottle, Bayer Healthcare Pharmaceuticals, NDC 11523-7234-4. recalled?

Yes. FDA published recall D-1319-2022 on August 17, 2022. Reported hazard: CGMP Deviations: products were stored outside the drug label specifications.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MIRALAX. UPC: 0041100820716.